Abstract：The concept of precision medicine has rapidly come into public view and become a hot spot for public and academic attention, and its essence is still individualized medicine. After the full opening of two children policy, the number of mothers with advanced maternal age has increased significantly, while the genetic and environmental factors have made it more difficult to prevent birth defects. Under the concept of precision medicine, the technology for screening, prevention, diagnosis and treatment of birth defects continues to advance, which demonstrates that the rapid development of precision medicine provides effective screening and diagnostic techniques for the prevention against birth defects and is conducive to reducing the occurrence of birth defects.
[1] 何明燕, 夏景林, 王向东. 精准医学研究进展[J].世界临床药物, 2015, 36(6):418-422. [2] 崔晓林. 中国将启动精准医疗计划 2030年前投入600亿元 “精准医学”会颠覆传统医疗产业吗? [J] . 中国经济周刊, 2015,23(39):36-38. [3] 李悦, 廖洪斐.“健康中国”背景下的精准医疗研究[J]. 企业经济, 2017,3(4):174-179. [4] Chen JS, Ma E, Harrington LB, et al. CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity[J]. Science, 2018, 360(6387):436-439. [5] Gootenberg JS, Abudayyeh OO, Kellner MJ, et al. Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6[J]. Science, 2018, 360(6387):439-444. [6] Liang Q, Shen X, Sun G. Precision medicine: update on diagnosis and therapeutic strategies of hepatocellular carcinoma[J]. Curr Med Chem, 2018,25(17):1999-2008. [7] Zhang J, Wolfgang CL, Zheng L. Precision immuno-oncology: prospects of individualized immunotherapy for pancreatic cancer[J]. Cancers, 2018, 10(2):39. [8] Yu L, Li K, Zhang X. Next-generation metabolomics in lung cancer diagnosis, treatment and precision medicine: mini review[J]. Oncotarget, 2017, 8(70):115774-115786. [9] Contreras AV, Cocomchan B, Hernandezmontes G, et al. Host-microbiome interaction and cancer: potential application in precision medicine[J]. Front Physiol, 2016, 7:606. [10] Umelo IA, Costanza B, Castronovo V. Innovative methods for biomarker discovery in the evaluation and development of cancer precision therapies[J]. Cancer Metastasis Rev, 2018, 37(1):125-145. [11] Dennis JM, Shields BM, Hill AV, et al. Precision medicine in type 2 diabetes: clinical markers of insulin resistance are associated with altered short-and long-term glycemic response to DPP-4 inhibitor therapy[J]. Diabetes Care, 2018, 41(4):705-712. [12] Brown SA, Pereira N. Pharmacogenomic impact of CYP2C19 variation on clopidogrel therapy in precision cardiovascular medicine[J]. J Pers Med, 2018, 8(1):8. [13] Ghayee HK, Vinik AI, Pacak K. Precision medicine in adrenal disorders: the next generation[J]. Endocr Pract, 2017, 23(6):672-679. [14] Hampel H, O’Bryant SE, Castrillo JI, et al. Precision medicine-the golden gate for detection, treatment and prevention of Alzheimer’s disease[J]. J Prev Alzheimers Dis, 2016, 3(4):243-259. [15] Guest FL, Guest PC, Martins-De-Souza D. The emergence of point-of-care blood-based biomarker testing for psychiatric disorders: enabling personalized medicine[J]. Biomark Med, 2016, 10(4):431-443. [16] 李宇斐, 刘海通, 曾可,等. 国际精准医疗领域研究热点分析[J]. 中华医学图书情报杂志, 2016, 25(1):24-29. [17] 胡颖, 王清蕊, 林卫,等. 孕前健康体检的现状分析及孕前保健的模式探讨[J]. 中国妇幼保健, 2015, 30(2):169-172. [18] 程文. 孕前健康体检的现状分析及孕前保健的模式研究[J]. 中国医药指南, 2017,15(1):179-180. [19] Atta CA, Fiest KM, Frolkis AD, et al. Global birth prevalence of spina bifida by folic acid fortification status: a systematic review and meta-analysis[J]. Am J Public Health,2016, 106(1):e24-34. [20] Liu S, Joseph KS, Luo W, et al. Effect of folic acid food fortification in Canada on congenital heart disease subtypes[J]. Circulation, 2016, 134(9): 647-655. [21] 杭桂芳, 许豪勤, 李素娟,等. Ⅲ级产前超声检查在出生缺陷二级预防中的应用价值[J]. 中国优生与遗传杂志, 2015,21(1):79-80. [22] de Jong A, de Wert GM. Prenatal screening: an ethical agenda for the near future[J]. Bioethics, 2015, 29(1):46-55. [23] 马邦雨, 何爱娟. 婚前医学检查用于新生儿出生缺陷预防效果探讨[J]. 实用预防医学, 2016, 23(3):352-353. [24] 章雪芹, 魏澄, 王栋,等. 遗传性耳聋基因筛查在新生儿听力筛查中应用研究[J]. 中国实用妇科与产科杂志, 2016,32(3):273-275. [25] 王翠翠, 袁慧军. 高通量测序技术在遗传性耳聋研究中的应用及研究进展[J]. 遗传, 2017, 39(3): 208-219. [26] Bianchi DW. From prenatal genomic diagnosis to fetal personalized medicine: progress and challenges[J]. Nat Med, 2012, 18(7):1041-1051. [27] Hercher L, Uhlmann WR, Hoffman EP, et al. Prenatal testing for adult-onset conditions: the position of the national society of genetic counselors[J]. J Genet Couns,2016, 25(1):1-7.
2019, Vol. 26 
